To wit, Biden’s FDA and USDA are advancing new regulations on food safety, school lunches, front of pack nutrition labeling, ...

Autolus Therapeutics has secured US Food and Drug Administration ... In April, the FDA mandated boxed warnings for these ...

It has been a year since the FDA announced their goals for the future ... or risk being deemed unsafe under the Federal Food, Drug, and Cosmetic Act. Like the labeling requirements for human drugs, ...

DWTX READ THE FULL DWTX RESEARCH REPORT Business Update Phase 2 Long COVID Results Expected Soon Dogwood Therapeutics, Inc.

The left-wing gender insanity being pushed in our children is an act of child abuse,” Trump said earlier this year in a ...

DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

Memorandum of Understanding has been signed NEW YORK, Nov. 11, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc ...

Orphan Drug Designation has been granted lately by US FDARAMAT GAN, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good afternoon, everyone, and welcome to the Atea Pharmaceuticals Third Quarter 2024 Financial Results and Business Update Conference Call.

Orphan Drug Designation has been granted lately by US FDA RAMAT GAN, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advan ...

Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in ...

MENSAH Given the controversies and broad spectrum of interests surrounding genetic engineering in agriculture, it is not surprising that different countries have developed and adopted diverse ...